Konstantin Poukalov Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Konstantin Poukalov.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Konstantin Poukalov. Konstantin Poukalov is a Director in Lyra Therapeutics, Inc. ($LYRA) and a EVP, Chief Financial Officer in Kadmon Holdings, Inc. ($KDMN) and an Executive Vice President, CFO in Kadmon Holdings, Inc. ($KDMN) and a Director in Landos Biopharma, Inc. ($LABP).
Address: C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET NEW YORK 10016 NY
Companies in which Konstantin Poukalov is an Insider
Kadmon Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Konstantin Poukalov: Executive Vice President, CFO, EVP, Chief Financial Officer
Holdings: 1,000 shares
Current Value: $3,990
Latest Transaction: Dec 12 2017
$KDMN Market Capitalization: $176.71M
$KDMN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Landos Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Konstantin Poukalov: Director
Holdings: 14,647,181 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lyra Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Konstantin Poukalov: Director
Holdings: 0 shares
Latest Transaction: May 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Konstantin Poukalov
Sentiment: All, KDMN, LABP, LYRA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 14.60 | 34,951 | 510,285 | 14,869,915 | 14.8 M to 14.9 M (+0.24 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 13.80 | 64,730 | 893,274 | 14,834,964 | 14.8 M to 14.8 M (+0.44 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 13.10 | 1,771 | 23,200 | 14,770,234 | 14.8 M to 14.8 M (+0.01 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 12.53 | 86,671 | 1,085,988 | 14,768,463 | 14.7 M to 14.8 M (+0.59 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 11.38 | 34,611 | 393,873 | 14,681,792 | 14.6 M to 14.7 M (+0.24 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 11.14 | 27,453 | 305,826 | 14,647,181 | 14.6 M to 14.6 M (+0.19 %) |
| Feb 08 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Option Exercise | C | 0.00 | 7,486,190 | 0 | 0 |